WallSt.net Updates Investment Community Through All-New Interview With Transplant... ( NEW YORK Jan. 16 /- On January 10...)

WallSt.net Updates Investment Community Through All-New Interview With Transplant Creations

Date:1/16/2008

NEW YORK, Jan. 16 /PRNewswire/ -- On January 10, Dr. Marlies Van Hoef, CEO of Transplant Creations (http://www.transplantcreations.com) updated the investment community in an all-new interview with http://www.wallst.net. Topics covered in the interview include an overview of the company, recent press, the market opportunity and upcoming milestones for which investors should watch.

To hear the interview in its entirety, visit the Company website at http://www.transplantcreations.com or go to http://www.wallst.net/audio/audio.asp?ticker=PRIVATE&id=4341.

About Transplant Creations:

Experienced in evaluation of the therapeutic potential of products, Transplant Creations' service department provides advice in strategic planning during the preclinical stage of development, during early or late stage clinical development, or at a moment that companies consider acquisition or development of a product in a therapeutic area within our focus.

Specialized in hematopoietic stem cell transplantation with a focus on malignant diseases and a back-ground in oncology and hematology the Company has developed a unique "delivery method" for "drug combinations", autologous stem cell support and allogeneic hematopoietic stem cell grafting.

The investment sector has been focusing on drugs and technologies as targets for investment, said Van Hoef, we focus on method development through same clinical research principles as drug development.

Van Hoef emphasized that there is an opportunity for investment in methods that has remained unexplored. The Company's unique method offers superior perspectives for disease outcome.

The mission for 2008 and beyond is to invite investors an
'/>"/>

0

GOOD

Page: 1 2
Related medicine news :

1. WallSt.net Announces Upcoming Interview With CEO of Avicena Group
2. WallSt.net Announces Upcoming Interview with CSO and COO of Urigen Pharmaceuticals
3. WallSt.net Announces Upcoming Interview With CEO of Alliance HealthCard
4. Skystar Bio-Pharmaceutical Announces Upcoming Interview With WallSt.net ( www.wallst.net )
5. WallSt.net (www.wallst.net) Updates the Investment Community Through All-New Interviews With XMDC, POSS and TYPE
6. WallSt.net Updates Investment Community Through All-New Interview With XTend Medical
7. WallSt.net Updates Investment Community Through All-New Interview With Ingen Technologies
8. PPD Updates 2007 Forecast; Issues Financial Guidance for 2008
9. Cardiome Updates Guidance
10. Silverchair Learning Systems Updates and Develops New Courses
11. eDiets.com(R) Updates Timing of Third Quarter 2007 Earnings Conference Call

Post Your Comments:

WallSt.net Updates Investment Community Through All-New Interview With Transplant...( NEW YORK Jan. 16 /- On January 10...),Health